Advertisement Inverness Medical acquires ParadigmHealth - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Inverness Medical acquires ParadigmHealth

Inverness Medical Innovations has said that it has completed the acquisition of ParadigmHealth. The transaction was structured as an all cash deal, with a purchase price of approximately $230 million.

The company is operating profitably and the past twelve months revenues were approximately $58.5 million.

ParadigmHealth, based in New Jersey, is a leading provider of innovative, consumer-centric decision support technologies and expert coaching to facilitate better health choices for acutely ill and clinically complex patients, including neonatal intensive care and oncology patients.